Terry A. Vik

3.1k total citations
79 papers, 2.1k citations indexed

About

Terry A. Vik is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Terry A. Vik has authored 79 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 26 papers in Pediatrics, Perinatology and Child Health and 24 papers in Oncology. Recurrent topics in Terry A. Vik's work include Childhood Cancer Survivors' Quality of Life (23 papers), Acute Lymphoblastic Leukemia research (16 papers) and Global Cancer Incidence and Screening (11 papers). Terry A. Vik is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (23 papers), Acute Lymphoblastic Leukemia research (16 papers) and Global Cancer Incidence and Screening (11 papers). Terry A. Vik collaborates with scholars based in United States, Kenya and Netherlands. Terry A. Vik's co-authors include John Ryder, Víctor Calvo, Barbara E. Bierer, Ann Mertens, Yutaka Yasui, Marilyn Stovall, Peter D. Inskip, Thomas R. Fears, Kevin C. Oeffinger and Charles A. Sklar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Terry A. Vik

71 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Terry A. Vik United States 24 795 558 473 439 379 79 2.1k
Pamela Kearns United Kingdom 26 830 1.0× 382 0.7× 470 1.0× 837 1.9× 487 1.3× 116 2.3k
Rajen Mody United States 24 540 0.7× 433 0.8× 377 0.8× 582 1.3× 264 0.7× 99 2.1k
Shiann‐Tarng Jou Taiwan 24 516 0.6× 335 0.6× 271 0.6× 355 0.8× 541 1.4× 118 1.9k
Selim Corbacioglu Germany 29 527 0.7× 303 0.5× 389 0.8× 643 1.5× 1.4k 3.6× 105 2.7k
Jerry Z. Finklestein United States 28 816 1.0× 537 1.0× 392 0.8× 327 0.7× 309 0.8× 57 2.2k
Stuart S. Winter United States 31 809 1.0× 607 1.1× 1.2k 2.6× 640 1.5× 984 2.6× 107 2.7k
Nobuko Hijiya United States 33 742 0.9× 1.1k 1.9× 1.6k 3.3× 623 1.4× 1.3k 3.3× 116 3.3k
Shripad Banavali India 22 304 0.4× 432 0.8× 638 1.3× 666 1.5× 349 0.9× 170 2.0k
C. Michel Zwaan Netherlands 38 1.7k 2.1× 647 1.2× 1.3k 2.7× 608 1.4× 2.1k 5.4× 152 3.9k
Alexander Gaiger Austria 32 957 1.2× 189 0.3× 479 1.0× 710 1.6× 872 2.3× 70 2.8k

Countries citing papers authored by Terry A. Vik

Since Specialization
Citations

This map shows the geographic impact of Terry A. Vik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terry A. Vik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terry A. Vik more than expected).

Fields of papers citing papers by Terry A. Vik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terry A. Vik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terry A. Vik. The network helps show where Terry A. Vik may publish in the future.

Co-authorship network of co-authors of Terry A. Vik

This figure shows the co-authorship network connecting the top 25 collaborators of Terry A. Vik. A scholar is included among the top collaborators of Terry A. Vik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terry A. Vik. Terry A. Vik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Njuguna, Festus, et al.. (2024). Clinical Impact of Project ECHO in Children With Cancer in Western Kenya: A Case Series. JCO Global Oncology. 10(10). e2400279–e2400279. 1 indexed citations
3.
Njuguna, Festus, et al.. (2024). A caregivers' perspective on social reintegration and stigma of childhood cancer survivors in Kenya. Psycho-Oncology. 33(5). e6345–e6345. 1 indexed citations
4.
Njuguna, Festus, et al.. (2023). Late effects of childhood cancer survivors in Africa: A scoping review. Critical Reviews in Oncology/Hematology. 185. 103981–103981. 3 indexed citations
7.
Langat, Sandra, et al.. (2023). Influence of health-insurance on treatment outcome of childhood cancer in Western Kenya. Supportive Care in Cancer. 31(8). 467–467. 6 indexed citations
8.
Vik, Terry A., et al.. (2022). The continuing evolution of a cancer prevention, screening, and survivorship ECHO: A second year of implementation. Cancer Medicine. 12(6). 7398–7405. 2 indexed citations
9.
Althouse, Sandra K., et al.. (2022). Early Discharge of Adolescent and Young Adult Patients During Induction Chemotherapy for Newly Diagnosed Acute Lymphoblastic Leukemia: Is It Safe?. Journal of Adolescent and Young Adult Oncology. 12(2). 271–274.
10.
Njuguna, Festus, Sandra Langat, Jodi Skiles, et al.. (2019). Influence of health insurance status on childhood cancer treatment outcomes in Kenya. Supportive Care in Cancer. 28(2). 917–924. 13 indexed citations
11.
Skiles, Jodi, Chien‐Wei Chiang, Ellen L. Smith, et al.. (2018). CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer. PMC. 5 indexed citations
12.
Njuguna, Festus, Sandra Langat, Jodi Skiles, et al.. (2017). Influence of health insurance status on paediatric non-Hodgkin’s lymphoma treatment in Kenya. BMJ Paediatrics Open. 1(1). e000149–e000149. 21 indexed citations
13.
Njuguna, Festus, Sandra Langat, Jodi Skiles, et al.. (2016). Wilms Tumor Treatment Outcomes: Perspectives From a Low-Income Setting. PMC. 2 indexed citations
14.
Njuguna, Festus, Sandra Langat, J. Musimbi, et al.. (2016). Factors influencing time to diagnosis and treatment among pediatric oncology patients in Kenya. Pediatric Hematology and Oncology. 33(3). 186–199. 41 indexed citations
15.
Rundell, Ann E., et al.. (2014). Optimal Chemotherapy for Leukemia: A Model-Based Strategy for Individualized Treatment. PLoS ONE. 9(10). e109623–e109623. 37 indexed citations
16.
Rosenman, Marc B., Terry A. Vik, Siu L. Hui, & Philip P. Breitfeld. (2005). Hospital Resource Utilization in Childhood Cancer. Journal of Pediatric Hematology/Oncology. 27(6). 295–300. 41 indexed citations
17.
Pradhan, Kamnesh R., Cynthia S. Johnson, Terry A. Vik, Leonard S. Sender, & Susan G. Kreissman. (2005). A novel intensive induction therapy for high‐risk neuroblastoma utilizing sequential peripheral blood stem cell collection and infusion as hematopoietic support. Pediatric Blood & Cancer. 46(7). 793–802. 11 indexed citations
18.
Dutt, Parmesh, Helmut Hanenberg, Terry A. Vik, David A. Williams, & Mervin C. Yöder. (1997). A recombinant human fibronectin fragment facilitates retroviral mediated gene transfer into human hematopoietic progenitor cells. IUBMB Life. 42(5). 909–917. 8 indexed citations
19.
Zhang, Xin & Terry A. Vik. (1997). Growth factor stimulation of hematopoietic cells leads to membrane translocation of AKT1 protein kinase. Leukemia Research. 21(9). 849–856. 14 indexed citations
20.
Calvo, Víctor, Michael A. Wood, Carl K. Gjertson, Terry A. Vik, & Barbara E. Bierer. (1994). Activation of 70‐kDa S6 kinase, induced by the cytokines interleukin‐3 and erythropoietin and inhibited by rapamycin, is not an absolute requirement for cell proliferation. European Journal of Immunology. 24(11). 2664–2671. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026